News - lald.org

Looking Beyond Fatty Liver

New evidence highlights the importance of considering LIPA variants in fatty liver disease A new study from the Nonalcoholic Steatohepatitis...

Important milestone for the LAL-D community in Italy We are pleased to see that the Italian Medicines Agency (AIFA) has approved the...

Don’t Miss a Beat: Your Heart Can Tell a Story About LAL-D Too On World Heart Day 2026, LAL-D Patient Organization joins the Cardioalianza...

LAL-D Patient Organization joins the European call to strengthen newborn screening and reduce inequalities across Europe LAL-D Patient...

FEETEG and LAL-D Patient Organization Renew Their Collaboration Agreement On September 3, 2026, the Spanish Foundation for the Study and...

New Research Identifies a Pathway Regulating Lysosomal Acid Lipase (LAL) Activity and Lysosomal Health Research into lysosomal diseases continues...

New Publication Expands Knowledge of Wolman Disease and Reports a Novel LIPA Variant A recent article published in Frontiers in Pediatrics...

New Research Project Explores Innovative Strategies for Lysosomal Acid Lipase Deficiency (LAL-D) At LAL-D Patient Organization, we would...

New International LAL-D Registry Study Shows Sustained Improvements in Lipid Profiles with Sebelipase Alfa Treatment A new study...

University of Rochester Seeks Participants for Final Validation Study of a New Lysosomal Acid Lipase Deficiency (LAL-D) Assessment Tool The...

LIPA c.894G>A: From Patients to Models A study recently accepted for publication in Scientific Reports describes the first mouse model...

“Lipids and Health” Conference: Early Diagnosis, Multidisciplinary Care and Access to Treatment...